On February 7, 2017 the FSUE Moscow Endocrine Plant held negotiations with representatives of the company Mundifarma Medical CEE GesmbH.
The company Mundifarma Medical CEE GesmbH is a large international manufacturer of prolonged-release analgesics used to relieve chronic pain syndrome in patients with malignant neoplasms.
During the meeting an agreement was reached on the possibility of expanding of the assortment portfolio of the FSUE Moscow Endocrine Plant by introduction of the list of drugs of Mundifarma Medical CEE GesmbH. Mutually beneficial cooperation in the field of contract production and participation in joint projects for the development and implementation of drugs are recognized to be promising areas for the further development of partnership relations.
The effective cooperation between the two companies carries not only commercial interest, but will also improve the quality of palliative care in the Russian Federation.
Comment type is not specified in the component properties.